Fulgent Genetics Files Q1 2025 10-Q
Ticker: FLGT · Form: 10-Q · Filed: May 2, 2025 · CIK: 1674930
| Field | Detail |
|---|---|
| Company | Fulgent Genetics, Inc. (FLGT) |
| Form Type | 10-Q |
| Filed Date | May 2, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, financials, medical-laboratories
TL;DR
Fulgent Genetics filed its Q1 2025 10-Q. Financials are in.
AI Summary
Fulgent Genetics, Inc. filed its 10-Q for the period ending March 31, 2025. The company, previously known as Fulgent Diagnostics, Inc., is based in El Monte, California. The filing details its financial performance and operational status for the first quarter of 2025.
Why It Matters
This filing provides investors and analysts with the latest financial and operational data for Fulgent Genetics, crucial for understanding the company's performance in the medical laboratory sector.
Risk Assessment
Risk Level: low — This is a routine quarterly filing providing standard financial information.
Key Players & Entities
- Fulgent Genetics, Inc. (company) — Filer of the 10-Q
- Fulgent Diagnostics, Inc. (company) — Former name of the filer
- El Monte, California (location) — Business address of the filer
- 20250331 (date) — Reporting period end date
FAQ
What is the reporting period for this 10-Q filing?
The reporting period for this 10-Q filing is March 31, 2025.
What is the company's primary business classification?
The company's Standard Industrial Classification is SERVICES-MEDICAL LABORATORIES [8071].
What was Fulgent Genetics, Inc. formerly known as?
Fulgent Genetics, Inc. was formerly known as Fulgent Diagnostics, Inc.
Where is Fulgent Genetics, Inc. located?
Fulgent Genetics, Inc. is located at 4399 Santa Anita Ave, El Monte, CA 91731.
When was the company's name changed?
The company's name was changed on May 17, 2016.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 2, 2025 regarding Fulgent Genetics, Inc. (FLGT).